23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.15%
Negative revenue growth while Insurance - Life median is 2.40%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-3.15%
Negative gross profit growth while Insurance - Life median is 2.40%. Seth Klarman would suspect poor product pricing or inefficient production.
4.42%
EBIT growth 1.25-1.5x Insurance - Life median of 3.42%. Mohnish Pabrai would see if the advantage stems from superior cost management or product pricing.
4.42%
Operating income growth near Insurance - Life median of 4.42%. Charlie Munger might chalk it up to standard industry trends.
6.58%
Net income growth exceeding 1.5x Insurance - Life median of 1.98%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
6.58%
EPS growth of 6.58% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
6.59%
Diluted EPS growth of 6.59% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-43.42%
Negative OCF growth while Insurance - Life median is -12.56%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-768.83%
Negative FCF growth while Insurance - Life median is -13.29%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
115.81%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 98.30%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
108.81%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 42.64%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
90.17%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 24.36%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
169.46%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 30.02%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
1006.76%
3Y OCF/share growth > 1.5x Insurance - Life median of 100.81%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
289.29%
Net income/share CAGR near Insurance - Life median. Charlie Munger might see typical industry-level profit expansion over 10 years.
255.91%
5Y net income/share CAGR > 1.5x Insurance - Life median of 139.77%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
139.06%
3Y net income/share CAGR > 1.5x Insurance - Life median of 86.03%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
229.42%
5Y equity/share CAGR > 1.5x Insurance - Life median of 74.60%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
152.16%
3Y equity/share CAGR > 1.5x Insurance - Life median of 39.20%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.15%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-2.82%
Negative BV/share change while Insurance - Life median is 0.00%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-50.19%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
204.46%
SG&A growth of 204.46% while Insurance - Life median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.